The Dangerous Drug Act, which encompasses Terminal Distributors of Dangerous Drugs (TDDD) licensure, was signed in to law in 1961. As a result, certain practices in Ohio had to obtain a TDDD license in order to handle or possess dangerous drugs. The verification rule (Admin. Code 4729-9-12) has been included in the Dangerous Drug Act for decades; however, the rule was recently amended in June of 2017 with modifications to exemptions related to practice type. In July of 2017, The Ohio Board of Pharmacy further clarified that TDDD licensure verification is required for delivery of drug samples to Ohio Healthcare Practitioners (HCPs).
For HCPs to receive a dangerous drug sample in Ohio, their practice address must be TDDD licensed. Because of this, HCP Sampleability® now exists at the address level. In order to help life science companies achieve this level of verification, the MedProID® suite of products utilizes TDDD licenses collected in our Organization database to obtain overall address eligibility for Ohio HCPs.download the MedPro Systems co-authored article which provides a comprehensive overview of Ohio Drug Distribution Verification requirements, or visit the OH Board of Pharmacy website: www.pharmacy.ohio.gov